Entheon Biomedical Corp.
ENBI
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -61.64% | -39.93% | -38.81% | -50.38% | -49.47% |
| Total Receivables | -34.78% | -62.50% | -42.31% | -92.13% | -85.26% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -15.62% | -58.65% | -50.86% | -47.67% | 105.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -55.93% | -41.78% | -40.09% | -55.49% | -46.93% |
|
|
|||||
| Total Current Assets | -55.93% | -41.78% | -40.09% | -55.49% | -46.93% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.70% | -50.00% | -79.89% | -79.89% | -80.00% |
| Total Assets | -55.30% | -41.94% | -41.85% | -56.40% | -48.00% |
|
|
|||||
| Total Accounts Payable | -58.17% | -53.15% | -48.09% | -67.33% | -39.48% |
| Total Accrued Expenses | 380.00% | -23.81% | -92.50% | -- | -95.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -54.85% | -51.14% | -53.44% | -66.06% | -44.97% |
|
|
|||||
| Total Current Liabilities | -54.85% | -51.14% | -53.44% | -66.06% | -44.97% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -54.85% | -51.14% | -53.44% | -66.06% | -44.97% |
|
|
|||||
| Common Stock & APIC | -2.41% | 3.98% | 3.24% | 3.39% | 2.86% |
| Retained Earnings | 4.87% | -4.76% | -4.18% | -3.66% | 1.67% |
| Treasury Stock & Other | -43.98% | 3.13% | 2.32% | -9.69% | -42.25% |
| Total Common Equity | -55.42% | -40.96% | -39.70% | -53.59% | -48.77% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -55.42% | -40.96% | -39.70% | -53.59% | -48.77% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -55.42% | -40.96% | -39.70% | -53.59% | -48.77% |
|
|
|||||